906.3500 -4.05 (-0.44%)
NSE Oct 06, 2025 15:31 PM
Volume: 67,670
 

906.35
-0.44%
ICICI Securities Limited
ICICI Securities Ltd | Retail Equity Research Revenues grew 33% YoY to | 863 crore (I-direct estimate: | 817 crore) on account of 40% YoY growth in domestic formulations to | 331 crore (I-direct estimate: | 327 crore), up 79% YoY in international (ex-US) business to | 126 crore (I-direct estimate: | 69 crore) and 38.5% YoY growth in API segment to | 180 crore EBITDA margins improved 186 bps YoY to 17.5% but came in lowerthan I-direct estimate of 20.0% mainly due higher other expenditure. EBITDA grew 48.8% YoY to | 151 crore...
Alembic Pharmaceuticals Ltd. has lost -27.07% in the last 1 Year
More from Alembic Pharmaceuticals Ltd.
Recommended